Literature DB >> 1774722

Stage I endometrial carcinoma. Role of omental biopsy and omentectomy.

S S Chen1, G Spiegel.   

Abstract

A prospective, routine histologic assessment of the omentum during primary surgery was conducted on 84 women with stage I endometrial carcinoma between February 1986 and June 1989. The purpose of the study was to determine the true incidence of omental involvement in early endometrial cancer and to detect risk variables associated with such metastases. Omental metastases were found in 7 (8.3%) of 84 patients with stage I endometrial carcinoma. A majority of the metastases (five) consisted of microscopic disease. Factors statistically significantly associated with omental metastasis were adnexal spread, cul-de-sac implantation, papillary serous carcinoma, a positive retroperitoneal lymph node and grade 3 tumor. The study indicated that silent metastases to the omentum frequently are neglected clinically in patients with stage I endometrial carcinoma during primary surgery and that a routine omental biopsy should be part of the procedure. Furthermore, for patients with high-risk variables, a complete omentectomy ought to be considered.

Entities:  

Mesh:

Year:  1991        PMID: 1774722

Source DB:  PubMed          Journal:  J Reprod Med        ISSN: 0024-7758            Impact factor:   0.142


  3 in total

1.  What is the importance of omental metastasis in patients with endometrial cancer?

Authors:  Taner Turan; Işın Ureyen; Alper Karalök; Tolga Taşçı; Hilal Ilgın; Levent Keskin; M Faruk Kose; Gökhan Tulunay
Journal:  J Turk Ger Gynecol Assoc       Date:  2014-08-08

2.  The role of omentectomy during the surgical staging in patients with clinical stage I endometrioid adenocarcinoma.

Authors:  Jale Metindir; Gülay Bilir Dilek
Journal:  J Cancer Res Clin Oncol       Date:  2008-04-02       Impact factor: 4.553

3.  Humanized mouse model of ovarian cancer recapitulates patient solid tumor progression, ascites formation, and metastasis.

Authors:  Richard B Bankert; Sathy V Balu-Iyer; Kunle Odunsi; Leonard D Shultz; Raymond J Kelleher; Jennifer L Barnas; Michelle Simpson-Abelson; Robert Parsons; Sandra J Yokota
Journal:  PLoS One       Date:  2011-09-15       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.